Selegiline as immunostimulant - A novel mechanism of action?

Journal of Neural Transmission, Supplement

Volumn , Issue 52, 1998, Pages 321-328

  Muller Th ^a   Kuhn, W ^a   Kruger R ^a   Przuntek, H ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; SELEGILINE; TUMOR NECROSIS FACTOR; CYTOKINE; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 1; MONOAMINE OXIDASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MALE; MONONUCLEAR CELL; NEUROPROTECTION; PRIORITY JOURNAL; ANALYSIS OF VARIANCE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; IMMUNOLOGY; MOUSE;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANALYSIS OF VARIANCE; ANIMALS; CELLS, CULTURED; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MONOAMINE OXIDASE INHIBITORS; SELEGILINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031596707     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6499-0_33     Document Type: Article

References (40)

1. Bartfai T, Schultzberg M (1993) Cytokines in neuronal cell types. Neurochem Int 22: 435-444
2. Bauer J, Strauss S, Schreiter Gasser U, Ganter U, Schlegel P, Witt I, Yolk B, Berger M (1991) Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett 285: 111-114
3. Blum-Degen D, Müller Th, Kuhn W, Gerlach M, Przuntek H, Riederer P (1995) Interleukin-1-beta and interleukin 6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett 202: 17-20
4. Boka G, Anglade P, Wallach D, Javoy Agid F, Agid Y, Hirsch EC (1994) Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci Lett 172: 151-154
5. Brosnan CF, Selmaj K, Raine CS (1988) Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol 18: 87-94
6. Cacabelos R, Barquero M, Garcia P, Alvarez XA, Varela de Seijas E (1991) Cerebrospinal fluid interleukin-1β (IL-1β) in Alzheimer's disease and neurological disorders. Meth Find Exp Clin Pharmacol 13: 455-458
7. Calne DB (1995) Selegiline in Parkinson's disease. BMJ 311: 1583-1584
8. Freisleben HJ, Lehr F, Fuchs J (1994) Lifespan of immunosuppressed NMRI-mice is increased by deprenyl. J Neural Transm [Suppl] 41: 231-236
9. Gatti S, Bartfai T (1993) Induction of tumor necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. Brain Res 624: 291-294
10. Gabellec MM, Griffais R, Fillion G, Haour F (1995) Expression of interleukin-1α, interleukin-1β and interleukin 1 receptor antagonist mRNA in mouse brain: regulation by bacterial lipopolysaccharide (LPS) treatment. Mol Brain Res 31: 122-130
11. Gerlach M, Riederer P, Youdim MB (1995) Neuroprotective therapeutic strategies. Comparison of experimental and clinical results. Biochem Pharmacol 50: 1-16
12. Glavin GB, Dugani AM, Pinsky C (1986) L-deprenyl attenuates stress ulcer formation in rats. Neurosci Lett 70: 379-381
13. Gottschall PE, Komaki G, Arimura A (1991) Interleukin-1β activation of the central nervous system. In: Rothwell N, Dantzer R (eds) Interleukin in the brain. Pergamon Press, Oxford, pp 27-49
14. Goujon E, Parnet P, Laye S, Combe C, Dantzer R (1996) Adrenalectomy enhances proinflammatory cytokines gene expression, in the spleen, pituitary and brain of mice in response to lipopolysaccharide. Mol Brain Res 36: 53-62
15. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL, Araoz C (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 86: 7611-7615
16. Hama T, Kushima Y, Miyamoto M, Kubota M, Takei N, Hatanaka H (1991) Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures. Neuroscience 40: 445-452
17. Hofman FM, Hinton DR, Johnson K, Merrill JE (1989) Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170: 607-612
18. Imamura K, Suzumura A, Hayashi F, Marunouchi T (1993) Cytokine production by peripheral blood monocytes/macrophages in multiple sclerosis patients. Acta Neurol Scand 87: 281-285
19. Imura H, Fukata J, Mori T (1991) Cytokines and endocrine function: an interaction between the immune and neuroendocrine systems. Clin Endocrinol 35: 107-115
20. Inglot AD, Zielinska Jenczylik J, Piasecki E, Syper L, Mlochowski J (1990) Organoselenides as potential immunostimulants and inducers of interferon gamma and other cytokines in human peripheral blood leukocytes. Experientia 46: 308-311
21. Knoll J (1995) Rationale for (-)deprenyl (selegiline) medication in Parkinson's disease and in prevention of age-related nigral changes. Biomed Pharmacother 49: 187-195
22. Kuhn W, Müller Th (1995) Neuroimmune mechanisms in Parkinson's disease. J Neural Transm [Suppl] 46: 217-228
23. Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW (1993) Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J Immunol 150: 2659-2667
24. McGeer PL, McGeer EG (1995) The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 21: 195-218
25. Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, Nagatsu T (1994a) Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett 180: 147-150
26. Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T (1994b) Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett 165: 208-210
27. Mogi M, Harada M, Kondo T, Riederer P, Nagatsu T (1995) Brain beta 2-microglobulin levels are elevated in the striatum in Parkinson's disease. J Neural Transm [Park Dis Dement Sect] 9: 87-92
28. Poli G, Kinter A, Justement JS, Kehrl JH, Bressler P, Stanley S, Fauci AS (1990) Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sci USA 87: 782-785
29. Selmaj K, Raine CS (1988a) Tumor necrosis factor mediates myelin damage in organotypic cultures of nervous tissue. Ann NY Acad Sci 540: 568-570
30. Selmaj K, Raine CS (1988b) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23: 339-346
31. Selmaj K, Bradbury K, Chapman J (1988a) Multiple sclerosis: effects of activated T-lymphocyte-derived products on organ cultures of nervous tissue. J Neuroimmunol 18: 255-268
32. Selmaj K, Nowak Z, Tchorzewski H (1988b) Interleukin-1 and interleukin-2 production by peripheral blood mononuclear cells in multiple sclerosis patients. J Neurol Sci 85: 67-76
33. Selmaj K, Papierz W, Glabinski A, Kohno T (1995) Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J Neuroimmunol 56: 135-141
34. Stoll S, Hafner U, Pohl O, Müller WE (1994) Age-related memory decline and longevity under treatment with selegiline. Life Sci 55: 2155-2163
35. Strijbos PJ, Rothwell NJ (1995) Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J Neurosci 15: 3468-3474
36. Tatton WG, Ansari K, Ju W, Salo PT, Yu PH (1995) Selegiline induces "trophic-like" rescue of dying neurons without MAO inhibition. Adv Exp Med Biol 363: 15-16
37. Thyagarajan S, Meites J, Quadri SK (1995) Deprenyl reinitiates estrous cycles, reduces serum prolactin, and decreases the incidence of mammary and pituitary tumors in old acyclic rats. Endocrinology 136: 1103-1110
38. Wollmann EE, Kopmels B, Bakalian A, Delhaye-Bouchard N, Fradelizi D, Mariani J (1992) Cytokines and neuronal degeneration. In: Rothwell N, Dantzer R (eds) Interleukin in the brain. Pergamon Press, Oxford, pp 187-203
39. Woodroofe MN (1995) Cytokine production in the central nervous system. Neurology 45: S6-S10
40. Yamaguchi M, Matsuzaki N, Hirota K, Miyake A, Tanizawa O (1990) Interleukin 6 possibly induced by interleukin 1 beta in the pituitary gland stimulates the release of gonadotropins and prolactin. Acta Endocrinol Copenh 122: 201-205